Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, People's Republic of China.
Braz J Cardiovasc Surg. 2024 Apr 17;39(3):e20210424. doi: 10.21470/1678-9741-2021-0424.
Intravenous non-volatile anaesthetics like propofol are commonly used in cardiac surgeries across several countries. Volatile anaesthetics like isoflurane may help in protecting the myocardium and minimize ischaemia-reperfusion injury. Hence, we did this review to compare the cardioprotective effect of isoflurane and propofol among patients undergoing coronary artery bypass grafting (CABG).
We conducted a search in the databases Medical Literature Analysis and Retrieval System Online (or MEDLINE), Embase, PubMed Central®, ScienceDirect, Google Scholar, and Cochrane Library from inception until April 2021. We carried out a meta-analysis with random-effects model and reported pooled risk ratio (RR) or standardized mean difference (SMD) with 95% confidence interval (CI) depending on the type of outcome.
We analysed 13 studies including 808 participants. Almost all were low-quality studies. For cardiac index, the pooled SMD was 0.14 (95% CI: -0.22 to 0.50); for cardiac troponin I, pooled SMD was 0.10 (95% CI: -0.28 to 0.48). For mortality, the RR was 3.00 (95% CI: 0.32 to 28.43); for MI, pooled RR was 1.58 (95% CI: 0.59 to 4.20); and for inotropic drug use, pooled RR was 1.04 (95% CI: 0.90 to 1.21). For length of intensive care unit stay, the pooled SMD was 0.13 (95% CI: -0.29 to 0.55), while pooled SMD for mechanical ventilation time was -0.02 (95% CI: -0.54 to 0.51).
Isoflurane did not have significant cardioprotective effect compared to propofol following CABG. Hence, the anaesthetists need to check some viable alternatives to manage these patients and reduce the rate of postoperative complications.
在多个国家的心脏手术中,常使用丙泊酚等静脉非挥发性麻醉剂。异氟醚等挥发性麻醉剂有助于保护心肌并最小化缺血再灌注损伤。因此,我们进行了这项综述,以比较冠状动脉旁路移植术(CABG)患者中异氟醚和丙泊酚的心脏保护作用。
我们在数据库 Medical Literature Analysis and Retrieval System Online(或 MEDLINE)、Embase、PubMed Central®、ScienceDirect、Google Scholar 和 Cochrane Library 中进行了检索,检索时间从建库至 2021 年 4 月。我们进行了荟萃分析,采用随机效应模型,并根据结局类型报告合并风险比(RR)或标准化均数差(SMD)及其 95%置信区间(CI)。
我们分析了 13 项研究,共纳入 808 名参与者。几乎所有研究均为低质量研究。对于心指数,合并 SMD 为 0.14(95%CI:-0.22 至 0.50);对于肌钙蛋白 I,合并 SMD 为 0.10(95%CI:-0.28 至 0.48)。对于死亡率,RR 为 3.00(95%CI:0.32 至 28.43);对于心肌梗死,合并 RR 为 1.58(95%CI:0.59 至 4.20);对于正性肌力药物的使用,合并 RR 为 1.04(95%CI:0.90 至 1.21)。对于重症监护病房停留时间,合并 SMD 为 0.13(95%CI:-0.29 至 0.55),而机械通气时间的合并 SMD 为-0.02(95%CI:-0.54 至 0.51)。
与丙泊酚相比,CABG 后异氟醚并无显著的心脏保护作用。因此,麻醉师需要寻找一些可行的替代方案来管理这些患者,以降低术后并发症的发生率。